Literature DB >> 31059101

Expression of tesmin (MTL5) in non‑small cell lung cancer: A preliminary study.

Jedrzej Grzegrzolka1, Agnieszka Gomulkiewicz1, Mateusz Olbromski1, Natalia Glatzel-Plucinska1, Aleksandra Piotrowska1, Katarzyna Ratajczak-Wielgomas1, Adam Rzechonek2, Marzena Podhorska-Okolow1, Zbigniew Krawczuk3, Piotr Dziegiel1.   

Abstract

Lung cancer is the most commonly diagnosed cancer and the most frequent cause of death worldwide. Tesmin (testis‑specific metallothionein‑like protein; MTL‑5) is a 60‑kDa protein which has cysteine‑rich motifs (CXC domain), characteristic of metallothioneins (MTs). Tesmin expression has been observed in germ cells during spermatogenesis, oogenesis and also in various cell nuclei after exposure to heavy metal ions. Yet, the role of tesmin in carcinogenesis is unknown. The aim of the present study was to evaluate the localization and intensity of tesmin expression in non‑small cell lung cancer (NSCLC) and its association with the clinicopathological data of patients. A total of 121 cases of NSCLC and 20 cases of non‑cancerous tissue samples from the surgical margin (control) were used for immunohistochemistry (IHC). In addition, 20 cases of frozen NSCLC tissues and 20 cases of control were used for the in vivo study. Normal lung fibroblasts (IMR‑90) and lung cancer cell lines NCI‑H1703 (lung squamous cell carcinoma), NCI‑H522 and A549 (both adenocarcinomas of the lung) were used for western blot analysis (WB) and RT‑PCR studies. Positive cytoplasmic tesmin expression was observed in 88.42% of the examined cases of NSCLC. Statistical analysis showed increased IHC tesmin expression in cancer cells compared to that noted in the controls. In addition, MTL5 mRNA and WB tesmin protein expression were also higher in cancer cases compared to the controls. A positive correlation between tesmin and Ki‑67 IHC expression was demonstrated (r=0.32; P<0.001). Higher WB tesmin expression was also associated with shorter overall survival (P<0.05, Mantel‑Cox test). The in vitro study revealed higher tesmin protein (WB) and MTL5 (qPCR) in lung cancer cell lines compared to the lung fibroblast control cell line. Higher tesmin expression in cancer cells compared to control cells may suggest a role of tesmin in NSCLC carcinogenesis. A positive correlation between tesmin and Ki‑67 could indicate a possible role of tesmin in the proliferation of NSCLC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31059101     DOI: 10.3892/or.2019.7145

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  Involvement of Dual Strands of miR-143 (miR-143-5p and miR-143-3p) and Their Target Oncogenes in the Molecular Pathogenesis of Lung Adenocarcinoma.

Authors:  Hiroki Sanada; Naohiko Seki; Keiko Mizuno; Shunsuke Misono; Akifumi Uchida; Yasutaka Yamada; Shogo Moriya; Naoko Kikkawa; Kentaro Machida; Tomohiro Kumamoto; Takayuki Suetsugu; Hiromasa Inoue
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

Review 2.  Microalgal Metallothioneins and Phytochelatins and Their Potential Use in Bioremediation.

Authors:  Sergio Balzano; Angela Sardo; Martina Blasio; Tamara Bou Chahine; Filippo Dell'Anno; Clementina Sansone; Christophe Brunet
Journal:  Front Microbiol       Date:  2020-04-28       Impact factor: 5.640

3.  Role of tesmin expression in non-small cell lung cancer.

Authors:  Jedrzej Grzegrzolka; Mateusz Olbromski; Agnieszka Gomulkiewicz; Aleksandra Piotrowska; Natalia Glatzel-Plucinska; Katarzyna Ratajczak; Patrycja Sputa-Grzegrzolka; Adam Rzechonek; Bozena Werynska; Marzena Podhorska-Okolow; Piotr Dziegiel
Journal:  Oncol Lett       Date:  2020-11-17       Impact factor: 2.967

4.  Metallothionein-like 5 expression is correlated with poor prognosis and promotes proliferation of cervical squamous cell carcinoma.

Authors:  Yi Huang; Qin Wu; Xiaoqing Tan
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.